Results 141 to 150 of about 385,811 (204)

Suboptimal vaccine coverage for preventable respiratory infections in children with cystic fibrosis in the Cystic Fibrosis Regional Reference Centre of Tuscany: Need for improving preventive strategies. [PDF]

Hum Vaccin Immunother
Forgione F, Canessa C, Taccetti G, Fevola C, Azzari C, Ricci S, Terlizzi V.   +6 more
europepmc   +1 more source

Light-assisted drying enables vaccine stabilization and supports cold-chain-independent distribution. [PDF]

Sci Rep
Tsegaye AA, Suptela AJ, Marriott I, Trammell SR.   +3 more
europepmc   +1 more source

Coxsackie B1 virus-like particle that lacks VP4 protein demonstrates improved vaccine scalability, stability and immunogenicity. [PDF]

J Biomed Sci
Soppela S, Kyröläinen HM, Levanova A, Nekoua MP, González-Rodríguez M, Lehto H, Ahmad KLL, Guryanov S, Hytönen VP, Laitinen OH, Junttila IS, Hober D, Butcher SJ, Hankaniemi MM.   +13 more
europepmc   +1 more source

The Role of Human Viral Entry Receptor Mouse Models in Advancing Antiviral Antibodies and Vaccines. [PDF]

Vaccines (Basel)
Zuo N, Zheng X, Ishaq R, Ren D, Hu A.
europepmc   +1 more source

Overcoming barriers to polio eradication in challenging subnational geographies: lessons from South Khyber Pakhtunkhwa, Pakistan, 2022-2024. [PDF]

Front Public Health
Khan H, Khawas S, Ali MW, Ameen A, Basit A, Hakim M, Akerele A, Franka R, Mohamed A.   +8 more
europepmc   +1 more source

Inequalities in adolescent HPV, Td/IPV and MenACWY vaccination coverage by socio-economic status: an ecological study, England, 2017 to 2024. [PDF]

Euro Surveill
Alvi MI, Viviani L, Hopkins S, Soldan K, Ismail S.   +4 more
europepmc   +1 more source

Erythema Multiforme Following Vaccination in a 4-Month-Old Infant. [PDF]

Am J Trop Med Hyg
Chauhan D, Sharma A, De D.
europepmc   +1 more source

Higher stability of novel live-attenuated oral poliovirus type 2 (nOPV2) despite the emergence of a neurovirulent double recombinant strain in Uganda. [PDF]

Nat Microbiol
Tushabe P, Majumdar M, Carlyle S, Shulman L, Ssekagiri A, Joffret ML, Klapsa D, Cremer J, Arowolo KO, Bujaki E, Bukenya H, EPI Laboratory team, Nanteza MB, Turyahabwe I, Namuwulya P, Birungi M, Eliku JP, Aine F, Tibanagwa M, Nakabazzi L, Gaizi J, Ssebuuma AM, Dhatemwa R, Okia C, Nyachwo M, Nanteza MB, Turyahabwe I, Namuwulya P, Birungi M, Eliku JP, Aine F, Tibanagwa M, Nakabazzi L, Gaizi J, Ssebuuma AM, Dhatemwa R, Okia C, Nyachwo M, Hawes KM, Bakamutumaho B, Duizer E, Bessaud M, Bandyopadhyay AS, Macadam A, Byabamazima CR, Martin J, Bwogi J.   +46 more
europepmc   +1 more source

Inactivated poliovirus vaccine following oral poliovirus vaccine cessation.

Releve epidemiologique hebdomadaire, 2006
openaire   +1 more source